Marimed (MRMD) Asset Writedowns and Impairment (2020 - 2026)
Marimed (MRMD) reported Asset Writedowns and Impairment of $76000.0 for Q1 2026, down 94.52% year-over-year from $1.4 million in Q1 2025, and up 26.67% quarter-over-quarter from $60000.0 in Q4 2025.
Marimed (MRMD) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Marimed (MRMD) has 7 years of Asset Writedowns and Impairment data on file, last reported at $76000.0 in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $76000.0, down 94.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $270000.0 (down 74.33% YoY), and the FY2025 annual result was $1.6 million, up 570.83% from the prior year.
- Asset Writedowns and Impairment improved to $76000.0 in Q1 2026 per MRMD's latest filing, from $60000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $3.8 million in Q4 2022 and troughed at -$205000.0 in Q4 2024.
- A 5-year average of $349733.3 and a median of $39000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment jumped 53500.0% in 2022, then plunged 414.29% in 2023.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $3.8 million in 2022, then sank by 93.47% to $245000.0 in 2023, then tumbled by 183.67% to -$205000.0 in 2024, then surged by 129.27% to $60000.0 in 2025, then grew by 26.67% to $76000.0 in 2026.
- Business Quant data shows MRMD's Asset Writedowns and Impairment at $76000.0 in Q1 2026, $60000.0 in Q4 2025, and -$122000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Marimed | - | - | 15.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76,000.00 |
| Mar 31, 2026 | 76,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | -122,000.00 |
| Sep 30, 2025 | -122,000.00 |
| Jun 30, 2025 | 256,000.00 |
| Jun 30, 2025 | 256,000.00 |
| Mar 31, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | -205,000.00 |
| Dec 31, 2024 | -205,000.00 |
| Sep 30, 2024 | -116,000.00 |
| Sep 30, 2024 | -116,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Dec 31, 2023 | 245,000.00 |
| Dec 31, 2023 | 245,000.00 |
| Sep 30, 2023 | -122,000.00 |
| Sep 30, 2023 | -122,000.00 |